Press release - 25/03/2026 The Influence of Lymph Node Architecture on Lymphoma For the first time, researchers have succeeded in mapping the organization of immune cells in human lymph nodes. The study was led by scientists from Heinrich Heine University Düsseldorf, Düsseldorf University Hospital, the DKFZ, the European Molecular Biology Laboratory (EMBL), and the Max Delbrück Center (MDC) in Berlin. They were able to demonstrate why the architecture of healthy lymph nodes is altered in malignant lymphomas.https://www.gesundheitsindustrie-bw.de/en/article/press-release/influence-lymph-node-architecture-lymphoma
Press release - 23/03/2026 Aggravated neuroimmune response, delayed wound healing Transcription factor NF-κB in astrocytes critically affects the outcome of traumatic brain injury (TBI) Traumatic brain injuries often lead to complications with long-lasting consequences on memory, concentration and movement control. Detrimental secondary inflammatory reactions at the injured tissue sites are often responsible for this. Researchers from Ulm have now shown that a transcription factor plays a key role in reactions to TBI. When this gene regulator is activated, an elevated neuroimmune response promotes inflammation.https://www.gesundheitsindustrie-bw.de/en/article/press-release/aggravated-neuroimmune-response-delayed-wound-healing-transcription-factor-nf-kb-astrocytes-critically-affects-outcome-traumatic
Press release - 23/03/2026 After a Heart Attack: Inflammation Weakens the Heart’s Energy Production Why does heart function often continue to deteriorate after a heart attack, even though blood flow has been restored? A research team from the DZHK sites Heidelberg and North has now identified an important mechanism: an inflammatory switch in cardiomyocytes can impair cellular energy production and thereby drive the development of heart failure. The results were published in Nature Communications.https://www.gesundheitsindustrie-bw.de/en/article/press-release/after-heart-attack-inflammation-weakens-hearts-energy-production
Press release - 23/03/2026 New findings on the first steps in Protein Synthesis In the earliest phase of creating human proteins, the protein complex NAC performs an essential task by starting the first steps towards folding proteins into their correct three-dimensional structures. This discovery was made by an international research team led by scientists from the Center for Molecular Biology of Heidelberg University. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-findings-first-steps-protein-synthesis
Press release - 19/03/2026 How old are we really? Ageing is a highly individual process. An international consortium coordinated by researchers in Konstanz has developed a method that uses biomarkers to determine a person's biological age – a valuable tool for research on ageing and the development of new approaches in preventive medicine.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-old-are-we-really
Press release - 12/03/2026 Brain Diseases: Certain Neurons Are Especially Susceptible to ALS and FTD Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) belong to a spectrum of neurodegenerative diseases with overlapping symptoms. Many patients have a common hallmark: A protein called TDP-43 clumps together in the neurons of the brain to form tiny lumps. Researchers at DZNE and Ulm University Hospital, together with international experts, have now discovered that these pathological changes primarily affect certain cells. https://www.gesundheitsindustrie-bw.de/en/article/press-release/brain-diseases-certain-neurons-are-especially-susceptible-als-and-ftd
Press release - 11/03/2026 Blood Marker for Alzheimer’s May also Be Useful in Heart and Kidney Diseases A certain blood protein regarded as an early indicator of Alzheimer’s disease also appears to play a role in other disorders. Researchers at DZNE and the Hertie Institute for Clinical Brain Research (HIH) at the University of Tübingen have found that elevated levels of phosphorylated tau protein (pTau) also occur in two lesser-known conditions that primarily affect the heart and kidneys.https://www.gesundheitsindustrie-bw.de/en/article/press-release/blood-marker-alzheimers-may-also-be-useful-heart-and-kidney-diseases
Press release - 10/03/2026 Advanced melanoma: Antibodies in the blood indicate side effects of immunotherapy Immunotherapies have greatly improved the treatment of metastatic melanoma, but they can cause serious side effects. A study led by researchers from Heidelberg University's Medical Faculty, the Heidelberg University Hospital, and the NCT in Heidelberg now shows that autoantibodies detected in the blood before the start of therapy could help to better assess the individual risk of side effects in patients.https://www.gesundheitsindustrie-bw.de/en/article/press-release/advanced-melanoma-antibodies-blood-indicate-side-effects-immunotherapy
Press release - 04/03/2026 Thermogenetics: How Proteins are controllable by heat Protein activity can be precisely regulated via subtle changes in temperature using heat-sensitive switches. Underlying this capability is a novel modular design strategy developed by researchers at the Institute of Pharmacy and Molecular Biotechnology of Heidelberg University. The strategy allows the integration of sensory domains in various proteins regardless of function or spatial structure.https://www.gesundheitsindustrie-bw.de/en/article/press-release/thermogenetics-how-proteins-are-controllable-heat
Press release - 03/03/2026 AI Chip Design From Heilbronn AI plays a huge role in the semiconductor industry, both by facilitating more efficient development processes and as a target application in development work. This is why the Fraunhofer Heilbronn Research and Innovation Centers HNFIZ are adding the Chip AI research and innovation center for AI chip design to their service range. The center is funded via the Dieter Schwarz Foundation. https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-chip-design-heilbronn
Press release - 02/03/2026 Novel therapy for Phelan-McDermid syndrome Drug development to be funded with up to 1.7 million euros An international team led by Professor Tobias M. Böckers from Ulm University Medical Centre has been awarded up to 1.7 million euros to develop a novel therapy for a rare, syndromic form of autism. The research project focuses on a gene whose loss of function can manifest itself in severe impairments in language, behaviour and everyday functions of those affected.https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-therapy-phelan-mcdermid-syndrome-drug-development-be-funded-17-million-euros
Press release - 26/02/2026 Mitochondria influence lipid storage in cells The powerhouse of the cells, known as mitochondria, appear to be able to influence the number of lipid droplets in the cell. Research into this previously unknown mechanism was conducted using baker’s yeast. This is shown by a recent study by the University of Freiburg, the University of Bonn and the University Hospital Bonn and the University of Freiburg. The results have now been published in the journal Nature Cell Biology.https://www.gesundheitsindustrie-bw.de/en/article/press-release/mitochondria-influence-lipid-storage-cells
Press release - 25/02/2026 Magnetic Microrobot Swarms Enable Contactless Manipulation of Objects Through Fluidic Torque In a study, a team of researchers show that groups of magnetic microrobots can generate fluidic forces strong enough to rotate objects in different directions without touching them. These microrobot swarms can turn gear systems, rotate objects much larger than the robots themselves, assemble structures on their own, and even pull in or push away many small objects. The work was now published in Science Advances.https://www.gesundheitsindustrie-bw.de/en/article/press-release/magnetic-microrobot-swarms-enable-contactless-manipulation-objects-through-fluidic-torque
Press release - 18/02/2026 New centre for cell research Technology impulse for the Lake Constance region: The new Single Cell Centre at the University of Konstanz offers technology and expertise to study cells individually and at high resolution – for applications in medical diagnostics, medication development and basic research at universities.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-centre-cell-research
Press release - 18/02/2026 Shingles vaccination could slow cognitive decline New findings indicate that a shingles vaccination could not only reduce the risk of cognitive impairment and dementia, but also reduce disease progression among those living with dementia. https://www.gesundheitsindustrie-bw.de/en/article/press-release/shingles-vaccination-could-slow-cognitive-decline
Press release - 17/02/2026 Tracing Tumors in Cerebrospinal Fluid: A New Opportunity for Precision Diagnostics in Brain Tumors In a published scientific study, researchers have succeeded in accurately diagnosing common types of brain tumors in children and adolescents based on tumor-derived genetic material in cerebrospinal fluid. Until now, these so-called liquid biopsies were not capable enough for such reliable diagnostics. The international research team has therefore optimized a sequencing technique and developed an AI-based computational method. In a later step,…https://www.gesundheitsindustrie-bw.de/en/article/press-release/tracing-tumors-cerebrospinal-fluid-new-opportunity-precision-diagnostics-brain-tumors
Press release - 13/02/2026 Molecular cause of radiation damage identified A severe side effect of radiation therapy can be debilitating fibrotic skin damage. Scientists at the German Cancer Research Center (DKFZ) have now identified a key factor in the development of this radiation damage. Modulating this factor could potentially prevent this severe adverse effect.https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-cause-radiation-damage-identified
Press release - 13/02/2026 How pancreatic cancer prepares tumour environment Possible biomarker for earliest stage of development Even before a tumour in the pancreas becomes discernible, an activated cancer gene actively remodels its future environment and creates an inflammatory and immune-defensive microenvironment in which the carcinoma can grow. The scientists' study opens up new possibilities for developing personalised intervention strategies - before a difficult-to-treat tumour even develops.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-pancreatic-cancer-prepares-tumour-environment-possible-biomarker-earliest-stage-development
Press release - 11/02/2026 The scent of a loved one makes the heart beat faster A study by researchers at the University of Freiburg investigates how the scent of one’s partner influences stress reactions. The study participants showed that the subconsciously perceived scent of their respective partners increased their subjective perception of stress and caused their heart rate to rise, especially when the scent was perceived as sexually attractive.https://www.gesundheitsindustrie-bw.de/en/article/press-release/scent-loved-one-makes-heart-beat-faster
Press release - 10/02/2026 CorTec Announces Successful Second Human Implantation of Its Brain-Computer Interface (BCI) System CorTec GmbH, a pioneer in active implantable medical technologies, announced the successful second implantation of its proprietary Brain-Computer Interface system in a clinical trial. The implantation follows neurological gains observed in the study’s first participant. This represents another key milestone to evaluate CorTec’s fully implantable closed-loop BCI platform for therapeutic applications.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cortec-announces-successful-second-human-implantation-its-brain-computer-interface-bci-system
Press release - 06/02/2026 nanodiag BW receives funding for second implementation phase nanodiag BW has received approval from the BMFTR for a further three-year implementation phase under the Clusters4Future initiative. With the approval of €15 million, the innovation network will be able to continue its work on nanopore-based diagnostic methods seamlessly from April 2026 onwards. The Baden-Württemberg Ministry of Economic Affairs, Labour and Tourism is supporting the cluster management through accompanying measures.https://www.gesundheitsindustrie-bw.de/en/article/press-release/nanodiag-bw-receives-funding-second-implementation-phase
Press release - 04/02/2026 A double-edged sword: Chronic cellular stress promotes liver cancer - but at the same time renders tumors vulnerable to immunotherapy A key molecular mechanism drives the growth of liver cell cancer while simultaneously suppressing the body's immune response to the tumor. This has now been published in the journal Nature by a team led by researchers from the DKFZ, the UKT, and the Sanford Burnham Prebys Medical Discovery Institute. However, the results also show that this very mechanism could help identify patients who respond particularly well to immunotherapy in the…https://www.gesundheitsindustrie-bw.de/en/article/press-release/double-edged-sword-chronic-cellular-stress-promotes-liver-cancer-same-time-renders-tumors-vulnerable-immunotherapy
Press release - 27/01/2026 Using AI to Retrace the Evolution of Genetic Control Elements in the Brain Artificial intelligence allows tracing the evolution of genetic control elements in the developing mammalian cerebellum. An international research team led by biologists from Heidelberg University as well as the Vlaams Instituut voor Biotechnologie and KU Leuven has now developed advanced AI models that can predict the activity of these elements based solely on their DNA sequence. https://www.gesundheitsindustrie-bw.de/en/article/press-release/using-ai-retrace-evolution-genetic-control-elements-brain
Press release - 26/01/2026 AI learns from animals: New approach to improve surgical imaging Scientists at the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD), and Mannheim University Medical Center (UMM) are presenting a method that enables artificial intelligence (AI) to learn how to transfer medical image data from animals to humans. This “xeno-learning” could help make surgical procedures safer and more precise in the future – without relying on human training data.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-learns-animals-new-approach-improve-surgical-imaging
Press release - 22/01/2026 NAKO study confirms link between smoking and depression A research group led by the Central Institute of Mental Health in Mannheim has confirmed for the first time within the German National Cohort an association between cigarette consumption and depression. The findings show that depression occurs more frequently over the lifetime of current and former smokers than among those who have never smoked. https://www.gesundheitsindustrie-bw.de/en/article/press-release/nako-study-confirms-link-between-smoking-and-depression